Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lipoprotein size and susceptibility to atherosclerosis--insights from genetically modified mouse models.

Current drug targets - 1 Mar 2008

Véniant Murielle M, Beigneux Anne P, Bensadoun André, Fong Loren G, Young Stephen G

Abstract excerpt

High plasma levels of the apo-B-containing lipoproteins are casually implicated in the pathogenesis of atherosclerosis. This finding, backed by decades of animal and human studies, has sparked interest in defining which classes of apo-B-containing lipoprotein particles are most atherogenic. Altho...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Animals, Genetically Modified
Share to Atherosclerosis
Share to Disease Models, Animal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Lipoproteins

Source

Open in PubMed Open full text

Identifiers

PMID: 18336235
DOI: 10.2174/138945008783755629
PMCID: PMC3034977

Genes

GPIHBP1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18336235-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lipoprotein size and susceptibility to atherosclerosis--insights from genetically modified mouse models.PMID 18336235Read ↗

Small rodent models of atherosclerosis.Semantic proximity Read ↗

HDL deficiency in genetically engineered mice requires elevated LDL to accelerate atherogenesis.Semantic proximity Read ↗

Chylomicronemia elicits atherosclerosis in mice--brief report.Semantic proximity Read ↗

Genetically modified mice for the study of apolipoprotein B.Semantic proximity Read ↗

Phenotypic analysis of mice expressing exclusively apolipoprotein B48 or apolipoprotein B100.Semantic proximity Read ↗

Genetic Modifiers of Atherosclerosis in MiceSemantic proximity Read ↗

Insights into apolipoprotein B biology from transgenic and gene-targeted mice.Semantic proximity Read ↗

Mouse models of hyperlipidemia and atherosclerosisSemantic proximity Read ↗

Mouse models of disturbed HDL metabolism.Semantic proximity Read ↗

The emergence of mouse models of atherosclerosis and their relevance to clinical researchSemantic proximity Read ↗

Understanding hyperlipidemia and atherosclerosis: lessons from genetically modified apoe and ldlr mice.Semantic proximity Read ↗

Mouse models of atherosclerosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.